The Beat

About Caitlin Donovan:Caitlin Donovan is the Global Head of Uber Health. She joined Uber most recently from MyOrthos, an Orthodontic Services Organization, where she served as Chief Operating Officer. Prior to that, Caitlin developed her knack for tackling obstacles to patient care as Chief Operating Officer of Circulation and Executive Vice President of Operations at LogistiCare (now ModivCare), specialty benefit managers in the non-emergency medical transportation space. She also served as the Vice President of Operations at CareCentrix with a focus on home health and post-acute care. Early in her career, she worked in finance as an investor at Bain Capital and as a member of the internal consulting group at Summit Partners. She earned her bachelor's degree in Economics from Harvard University and lives in Dover, Massachusetts with her husband and two boys. Things You’ll Learn:Medicaid has had transportation as a covered benefit since 1966, but it’s not a benefit many know how to access.Health plans are increasingly looking to include transportation within their benefits portfolio.According to a recent study, within 5.1 million employees under self-insured employers, 27% live at 200% of the poverty line or below. The above-mentioned population uses preventative services 50% less, resulting in four times more avoidable admissions.To register for WIC, it is required to go in person to an office before getting groceries delivered.Logistics and value-based care will not solve healthcare’s problems on their own; It is important to think about the underlying issues to address them in a scalable way while they align with the system’s incentives. Resources:Connect with and follow Caitlin Donovan on LinkedIn.Follow Uber Health on LinkedIn.Visit the Uber Health Website.

For most cancers, Black Americans have the highest death rate and shortest survival of any patient population.And access to genetic testing is key to eliminating this disparity.Feyi Olopade Ayodele is Cofounder and CEO of CancerIQ, a company on a bold mission to end cancer as we know it by giving providers and health systems access to the latest innovations in early cancer detection and prevention.Under Feyi’s leadership, CancerIQ has grown its provider network to over 200 locations across the US and established a robust ecosystem of leading diagnostic and genomic testing vendors.On this episode of The Beat, Feyi joins host Dr. Jessica Shepherd to explain how she built CancerIQ to solve for the disparity in access to genetic testing by making it part of everyone’s primary care visit.Feyi describes how CancerIQ helps patients initiate conversations around cancer prevention with their providers and gives providers the right precision prevention program for each patient. Listen in for Feyi’s insight on the emotional journey associated with a cancer diagnosis and learn how CancerIQ is helping African American and rural patient populations prevent cancer or detect it in its earliest stages. Topics CoveredDisparities in breast cancer outcomes between Black women and other patient populationsWhy Feyi built CancerIQ to solve for the disparity in access to genetic testingHow CancerIQ makes it easy for providers to navigate patients to the right precision cancer prevention programWhy Feyi encourages primary genetic care vs. specialty genetic careHow CancerIQ helps patients initiate conversations on cancer prevention with their providersHow CancerIQ is closing the gap for African American and rural patient populationsWhat CancerIQ does to help patients adhere to a cancer prevention planHow CancerIQ recognizes the emotional journey associated with a cancer diagnosisFeyi’s vision to make CancerIQ part of everyone’s preventative care visit and detect cancer in its earliest stages Connect with Feyi Olopade AyodeleCancerIQ Connect with Dr. Jessica ShepherdHLTHDr. Shepherd on TwitterDr. Shepherd on LinkedIn  ResourcesNCCN GuidelinesSmall Talk Baby Podcast

About Jean Drouin:Jean is a leader with over 25 years of experience in healthcare management, technology, operations, finance, and cultural change. As CEO, Jean focuses on creating the environment that allows Clarify to deliver on its mission by delighting customers and growing a great team. Jean leads the Executive Leadership Team which sets the company’s vision and strategy and is responsible for ensuring the company’s overall success. Jean believes that healthcare has been held back by a lack of actionable insights and that by integrating innovative analytics and incentives, we can power better health and outcomes.  Prior to founding Clarify, Jean was a Senior Partner at McKinsey, where he led the Healthcare Digital and IT practice. He also built and served as the founding Head of McKinsey Advanced Healthcare Analytics (MAHA), which provided services and products on healthcare reform, consumer analytics, new payment and pricing models, and risk management. Jean spent several years in the UK, where he helped set up the hospital regulator and served as the Head of Strategy for NHS London, a $15 billion organization that oversaw London’s hospitals, primary and social care.   Jean holds an MD and MBA from Stanford University and an AB in Molecular Biology from Princeton. He is a Trustee of the Mailman School of Public Health at Columbia University, and the former Vice-Chair of the Board of Lester B. Pearson United World College of the Pacific. Things You’ll Learn:The United States Health System is the only one in the world with the granularity of information to understand patient journeys in an actionable way.The FDA has a very high standard around the data collected for a clinical trial, which is why recruiting patients takes a long time.Machine Learning and AI tools can be beneficial in automating data pipelines to turn them into the cleanest possible analytics fuel.Value-based payments haven't scaled as expected because doctors aren’t excited about a model that looks at their yearly performance to give them a bonus. Paying clinicians shouldn’t be exclusively transactional but more collaborative and team-based.Resources:Connect with and follow Jean Drouin on LinkedIn.Follow Clarify Health on LinkedIn.Explore the Clarify Health Website.

Isabelle Kenyon, Founder and CEO of Calibrate, discusses how her program treats obesity as a chronic disease. The podcast explores the importance of combining medication and lifestyle interventions for long-term success. It also delves into the role of coaches and community support, challenges of habit formation, and the need to change the perception of obesity.

About Thom Bales:Thom is a Principal in Strategy&, a part of the PwC network. He leads PwC’s Health Services Sector with responsibility for our payer-provider and digital health growth. He has over 20 years of management consulting experience, originally with Booz Allen Hamilton/ Booz & Company merged with PwC to become Strategy&. He has expertise in health services growth, operations, technology strategy, and transformation. He has co-authored several articles including the industry-leading viewpoint “5 PMPM Healthplan”, “PwC’s Next In Health, 2022” and managing change and the investment bulge as well as a co-host of PwC’s Health 180 Forums.Thom’s past work has included capabilities-based growth strategy, technology-enabled business, and cost transformations, payer-provider collaboration strategy, consumer engagement strategies, as well as assessment of merger, acquisitions, and divestitures for his clients. He has led some of the largest business-led payer technology transformations and growth programs in the industry in the past 10 years.Thom earned his M.B.A. with high distinction at the University of Michigan; MS, Chemistry, Georgia Institute of Technology; and BA Chemistry, BA Economics, Cornell University.About Patty Obermaier:As Vice President of Microsoft US Health and Life Sciences business, Patty is responsible for growing Microsoft's solutions, services, and support revenues across enterprise health customers in the United States. She leads a 950-person team and is accountable for a $5B P&L. Patty holds a bachelor’s degree in biology from the Massachusetts Institute of Technology and an M.B.A. from the Darden School at the University of Virginia. Things You’ll Learn:During COVID, many people couldn't access virtual health because they didn't have broadband or the appropriate devices to do so.Out of 8 billion people on Earth, 4 billion do not have access to healthcare, and a billion have disabilities, 70% of which can't be seen.The average family in the United States has a family income of around $60,000 of which roughly half does to insurance, healthcare, and out-of-pocket costs.Patients can now request their information, which has to be made available and stored for them, and they have to be able to take it with them wherever they want.Health equity is about understanding who we are as individuals, where we’re at, and what we need to get to our definition of health.Most healthcare companies are now focusing on improving patient experience.Resources:Connect with and follow Thom Bales on LinkedIn.Connect with and follow Patty Obermaier on LinkedIn.Follow Strategy& on LinkedIn.Visit the Strategy& Website!Follow PwC on LinkedIn!Explore the PwC Website!Follow Microsoft US Health and Life Sciences on LinkedIn.Discover the Microsoft US Health and Life Sciences Website.

When Krista Drobac first started thinking about home-based health care, she assumed that the biggest barriers to adoption would be cultural. But she quickly learned that policy was the problem.And then came COVID-19. Regulations were loosened, and we were allowed to experiment with caring for patients at home. So, how do we convince policymakers to preserve the advances in home-based care made during the pandemic and change the rules for good?Krista serves as Partner at Sirona Strategies, Executive Director of the Alliance for Connected Care and Founder of Moving Health Home,  a coalition working to change policy to enable the home to be a clinical site of care. Krista has 25 years of experience in federal and state government policy and public affairs, and she consults on Medicare, Medicaid, digital health, social determinants of health and new care models. On this episode, Krista joins hosts Dr. Jessica Shepherd, Dr. Gautam Gulati and Dr. Jordan Schlain to explore the innovations in hospital-at-home and SNF-at-home we achieved during the pandemic. Krista discusses who benefits most from home-based care (and who might want to opt out) and describes how providers can identify environmental risks when they’re in a patient’s home. Listen in to understand why Krista advocates for value-based reimbursement models and learn what you can do to help persuade legislators to embrace home-based care. Topics CoveredThe regulatory barriers to moving health care into the home prior to the pandemicHow Moving Health Home was launched to preserve the innovation and advances in home-based care made during COVIDWho benefits most from home-based care and who might want to opt outWhat the hospital-at-home model looks like and how it took off during the pandemicThe regulatory challenges Moving Home Health faces in executing SNF-at-homeHow home-based care allows providers to identify environmental risksWhy value-based care reimbursement models are more appropriate for home-based care than fee-for-serviceHow home-based care might improve a patient’s mental and emotional healthWhy we need a large-scale demonstration of the benefits of home-based care to change policyThe power of patient voice in convincing legislatures and hospital systems to embrace home-based careHow we might incentivize or persuade Americans to choose healthy foodHow the social determinants of health or SDOH are influenced by policy Connect with Krista DrobacMoving Health Home Connect with Dr. Jessica Shepherd, Dr. Gautam Gulati & Dr. Jordan ShlainHLTHDr. Shepherd on TwitterDr. Shepherd on LinkedInDr. Gulati on TwitterDr. Gulati on LinkedInDr. Shlain on TwitterDr. Shlain on LinkedIn ResourcesAmerica’s Essential HospitalsCMS COVID WaiversMoving Health Home StudiesWhite House Conference on Hunger, Nutrition and HealthSocial Determinants of Health

Starting a company in the healthcare space is incredibly difficult, as founders face regulatory hurdles, high security standards and complicated reimbursement policies, among many other challenges. But what if you had an expert to help you assemble a founding team and shepherd you through the first 15 months of being a startup? What if there was a platform to streamline the complex process of launching a health company? Missy Krasner is Venture Chair at Redesign Health, where she sits on the boards for Uplift, Overalls and Motto. A seasoned healthcare operator, Missy has more than 30 years of experience in digital health, most notably serving as a founding member of the Alexa Health & Wellness Team at Amazon. On this episode, Missy joins host Dr. Jessica Shepherd to discuss how Redesign Health serves as a company creation platform for healthcare services, describing how her team bends the risk curve for digital health startups.Missy walks us through some of the obstacles to providing services and solutions in the health tech space and weighs in on what we might do to fix the issues with electronic medical records.Listen in to understand how Redesign creates efficiencies in the process of launching companies across the healthcare spectrum, meeting the needs of patients and providers while keeping pace with the trajectory of science and research.Topics CoveredMeeting the needs of patients and providers while keeping pace with scienceHow Redesign Health serves as a company creation platform for healthcare servicesWhat Redesign does to bend the risk curve for digital health startupsThe obstacles to providing services and solutions in the health technology spaceHow we might change the perverse incentives in healthcare to reward qualityWhat the competition among big tech and retailers to own consumer-centric virtual primary means for hospitals, health systems and patientsRedesign Health’s strength in assembling founding teams for healthcare companiesWhy so many providers struggle to stay up to speed on innovationHow Missy thinks about fixing the problems with electronic medical recordsWhy it’s so challenging to get medical records from point A to point B Connect with Missy KrasnerRedesign Health Connect with Dr. Jessica ShepherdHLTHDr. Shepherd on TwitterDr. Shepherd on LinkedIn ResourcesPractice FusionDoximityHealthLoopVita HealthGoogle HealthZus HealthParticle HealthHuman APIMedicare AdvantageMedicare Supplement InsuranceDr. David BrailerOffice of the National Coordinator for Health Information TechnologyProtected Health Information

About Manny Montalvo:Manny Montalvo is SVP, Head of Digital Health & Innovation at Teva Pharmaceuticals since September 2021. Manny is responsible for overseeing the US Respiratory business, the US commercial innovation work, and the US and GLOBAL DIGIHALER® franchise. Manny’s digital health team at Teva is entirely homegrown and has pioneered a class of digital pharmaceutical devices - a rarity in the pharmaceutical industry. Manny’s charge at Teva is to encourage the use of digital therapeutics as part of the healthcare experience, making it seamless for both the healthcare providers and the patients they serve. With over 20 years of life-science experience, Manny Montalvo has held leadership roles in both Sales and Marketing, working in numerous therapeutic areas in the US and global markets, as well as in R&D and Commercial Operations. Prior to assuming his current role, Manny Montalvo served as the Vice President of Global Digital Health Marketing & Commercial Analytics at Teva Pharmaceuticals where he set the strategic direction for Teva’s biologic program and Digital Health Marketing and transformation of Teva’s Global Commercial Analytics. Manny joined Teva in 2013 to lead its R&D Innovation program as Vice President of Global New Therapeutic Entities (NTE) Innovation where he focused on the evaluation of the latest drug delivery technologies and drug development, adding more than 15 new products to Teva’s specialty portfolio. Before joining Teva, Manny held leadership positions with P&L responsibilities at Sanofi and Johnson & Johnson. During his tenure at Sanofi and J&J, Manny worked in a variety of commercial roles including consumer marketing, driving growth for a range of portfolios including diabetes, dermatology, cardiovascular and primary care.  Things You’ll Learn:Two out of five medicines in your cabinet are likely from Teva.A platform business has a feedback loop with customers.To innovate, one has to have a collaborative space supported by management.Teva Pharmaceuticals is partnering with Rimidi and HealthSnap, integrating their data as a step closer to fulfilling their mission. The more patients on Teva’s platform, the better the technology gets.About 40% of Teva’s digital space workers did not come from the traditional pharma industry. Resources:Connect with and follow Manny Montalvo on LinkedIn.Follow Teva Pharmaceuticals on LinkedIn.Visit the Teva Pharmaceuticals Website!Discover DIGIHALER here!

Morgan Health is focused on improving the quality, equity, and affordability of employer-sponsored healthcare in the U.S. by investing capital in companies focused on improving healthcare in the commercial marketplace. As the Head of Healthcare Innovation at Morgan Health, Rivka Friedman is focused on improving the quality, equity, and affordability of employer-sponsored healthcare in the U.S. by accelerating the adoption of new approaches to care delivery. On this episode, Rivka joins hosts Dr. Jessica Shepherd and Dr. Jordan Shlain to discuss how Morgan Health is working to invest in companies that share their vision of BETTER care. Listen in as Rivka shares how you build trust in the healthcare system and the three things that need to align to improve healthcare for the future. Topics CoveredThe focus of Morgan health in improving employer-sponsored healthcareThe key lessons Morgan Health learned from the failed HavenRivka weighs in on the trend of the productization of healthcareRivka shares a few of the companies they are currently working withHow Morgan Health defines accountable careRivka shares what success looks like for Morgan HealthThe 3 Biggest challenges Morgan Health is facingHow to build trust in the healthcare systemRivka shares what motivates her to keep going to improve healthcare Connect with Rivka FriedmanRivka on LinkedInMorgan Health Connect with Dr. Jessica Shepherd, Dr. Guatam Gulati & Dr. Jordan ShlainHLTHDr. Shlain on TwitterDr. Shlain on LinkedInDr. Jessica Shepherd MDDr. Shepherd on TwitterDr. Gulati on TwitterDr. Gulati on LinkedIn Resources A Visual Approach to Leverage Points - The Donella Meadows ProjectEmbold HealthVera Whole HealthCentivoLetsGetChecked   Introductory Quote[30:18]“One key goal for us across all of our teams is figuring out what works and then scaling it. To do that, we have to try a lot of things and fail. So that's part of our job, launching these pilots, and then letting a bunch of them not work, and being honest and open both about our successes and our failures.”

About Theresa Demeter:Theresa Demeter is an entrepreneurial executive administrator with 30 years of healthcare performance and operational experience. In her role as a Managing Director at Tegria, she brings her passion for conceptualizing and implementing innovative solutions that drive quality and performance improvement to optimize patient outcomes. Theresa developed Tegria’s offering that helps healthcare organizations prioritize and operationalize their health equity strategy and mitigate the harmful effects of implicit bias through macro-simulation.Prior to joining Tegria, Theresa drove the formation and expansion of InSytu, a national leader in clinical process improvement consulting powered by macro-simulation. She also served as the Director of Women and Infants Outpatient Services at Swedish Health Services in Seattle.Theresa earned a master’s degree in healthcare administration from the University of Washington and is a certified childbirth and parenting educator and doula. Things You’ll Learn:Technology can depend significantly on having access to a high-quality broadband service, something that some people still don’t have daily.Healthcare companies should always devise their health tech solutions thinking of access issues for people in rural settings and income issues for people in urban environments.Techquity is the intentional and thoughtful development of healthcare-related technology without excluding anybody.On some occasions, people have better health outcomes when they can stay within their community rather than moving away from them.Health advocates are people who build trust by bridging health companies with communities.Healthcare has to make partnerships to address issues that affect a patient’s health, like their social determinants.Resources:Connect and follow Theresa Demeter on LinkedInFollow Tegria on LinkedIn Discover the Tegria WebsiteListen to Theresa’s previous interview from ViVe here!Visit the HLTH Foundation Website!Check out Tegria’s pictures of their trip to Alaska here!